AI assistant
Dare Bioscience, Inc. — Director's Dealing 2017
Dec 8, 2017
34825_dirs_2017-12-08_eb699d3e-b487-4566-a1bd-b5a536773a7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2017-07-19
Reporting Person: RASTETTER WILLIAM H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-19 | Option to Purchase Common Stock | $6.56 | A | 2000 | Acquired | 2027-07-19 | Common Stock (2000) | Direct |
Footnotes
F1: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017.
F2: Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan.
F3: This form amends a Form 4 previously filed for Dr. Rastetter on July 21, 2017, to correct the description of the vesting schedule of the stock options.
F4: The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders.